#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma metastatic Growth hormone deficiency CDKL5 deficiency disorder Astrocytoma Acquired ATTR amyloidosis Small intestine neuroendocrine tumour Thromboangiitis obliterans Follicular lymphoma Aicardi-Goutieres syndrome Intracranial calcification Non-small cell lung cancer T-cell lymphoma Pericarditis Prader-Willi syndrome Bronchopulmonary dysplasia More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Basic Information Primary hyperoxaluria – Diagnostics Hypereosinophilic syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Trials in Disease Acute respiratory distress syndrome – Treatment Angelman’s syndrome – Basic Information Primary biliary cholangitis – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Pulmonary sarcoidosis – Diagnostics Rosai-Dorfman syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Perindopril Tert-Butylamine Immunoglobulin G GSKVX000000040033 Cladribine Sxr1096 Arrhenatherum Elatius Metamizole Xaluritamig Ucart20X22 Pioglitazone Letetresgene Autoleucel Ripretinib Pentetic Acid Ociperlimab Tadalafil ZUNIBERGENE ROCPARVOVEC Dutasteride Loncastuximab Tesirine Brinzolamide Guanabenz Acetate More therapies…

    Learn about Your Condition

    Chronic hepatitis B Peptostreptococcus infection Developmental hip dysplasia Angina pectoris Biliary cancer metastatic Endometrial cancer stage IV Oesophagectomy Abortion threatened Mixed dementia Bile duct cancer Autoimmune hepatitis Agitation Metabolic syndrome Choroidal dystrophy Lymphangioleiomyomatosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Slovakia

  • Study on Izokibep for Patients with Non-infectious Uveitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Chorioretinitis
    • Uveitis
    Investigated Drugs:
    • Izokibep
    Austria Czechia France Germany Italy Spain

  • Study on the Effectiveness of Dexamethasone Implant for Patients with Diabetic Macular Edema

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dexamethasone
    France

  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    • Aflibercept
    Austria Bulgaria Croatia Czechia Estonia France +10

  • Study on Atropine Sulfate Eye Drops to Slow Down Myopia in European Children

    Not recruiting

    2 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    • Placebo
    Germany

  • Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    • Ranibizumab
    Czechia Denmark France Germany Greece Hungary +4
Previous Page
1 … 22 23 24 25 26 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!